Mediwound Stock Performance
| MDWD Stock | USD 16.90 0.43 2.48% |
The company secures a Beta (Market Risk) of 1.41, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mediwound will likely underperform. At this point, Mediwound has a negative expected return of -0.16%. Please make sure to verify Mediwound's potential upside, and the relationship between the jensen alpha and daily balance of power , to decide if Mediwound performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mediwound has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (0.52) | Five Day Return 2.68 | Year To Date Return 53.24 | Ten Year Return (56.33) | All Time Return (85.74) |
Last Split Factor 1:7 | Last Split Date 2022-12-20 |
1 | MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 09/03/2024 |
2 | Wound Care Market Research Report 2018-2032 Industry Size, Shares, Acquisitions, Recent Developments, Takeaways by Sector | 10/04/2024 |
3 | Xencor Reports Q3 Loss, Tops Revenue Estimates | 11/06/2024 |
4 | Durect Reports Q3 Loss, Misses Revenue Estimates | 11/13/2024 |
5 | MediWound Q3 2024 Earnings Preview | 11/25/2024 |
| Begin Period Cash Flow | 33.9 M |
Mediwound |
Mediwound Relative Risk vs. Return Landscape
If you would invest 1,917 in Mediwound on August 28, 2024 and sell it today you would lose (227.00) from holding Mediwound or give up 11.84% of portfolio value over 90 days. Mediwound is currently does not generate positive expected returns and assumes 2.8908% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Mediwound, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mediwound Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mediwound's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mediwound, and traders can use it to determine the average amount a Mediwound's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0538
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDWD |
Estimated Market Risk
| 2.89 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mediwound is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mediwound by adding Mediwound to a well-diversified portfolio.
Mediwound Fundamentals Growth
Mediwound Stock prices reflect investors' perceptions of the future prospects and financial health of Mediwound, and Mediwound fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mediwound Stock performance.
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.99) % | ||||
| Operating Margin | (0.89) % | ||||
| Current Valuation | 164.13 M | ||||
| Shares Outstanding | 10.79 M | ||||
| Price To Earning | 16.58 X | ||||
| Price To Book | 10.46 X | ||||
| Price To Sales | 9.28 X | ||||
| Revenue | 18.69 M | ||||
| Gross Profit | 13.16 M | ||||
| EBITDA | (4.89 M) | ||||
| Net Income | (6.72 M) | ||||
| Cash And Equivalents | 10.41 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 6.35 M | ||||
| Debt To Equity | 0.64 % | ||||
| Current Ratio | 1.61 X | ||||
| Book Value Per Share | 1.92 X | ||||
| Cash Flow From Operations | (10.46 M) | ||||
| Earnings Per Share | (2.16) X | ||||
| Market Capitalization | 186.99 M | ||||
| Total Asset | 66.46 M | ||||
| Retained Earnings | (174.82 M) | ||||
| Working Capital | 38.87 M | ||||
| Current Asset | 50.4 M | ||||
| Current Liabilities | 5.21 M | ||||
About Mediwound Performance
By analyzing Mediwound's fundamental ratios, stakeholders can gain valuable insights into Mediwound's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mediwound has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mediwound has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 68.76 | 65.32 | |
| Return On Tangible Assets | (0.10) | (0.11) | |
| Return On Capital Employed | (0.27) | (0.29) | |
| Return On Assets | (0.10) | (0.11) | |
| Return On Equity | (0.21) | (0.22) |
Things to note about Mediwound performance evaluation
Checking the ongoing alerts about Mediwound for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mediwound help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mediwound generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 18.69 M. Net Loss for the year was (6.72 M) with profit before overhead, payroll, taxes, and interest of 13.16 M. | |
| Mediwound currently holds about 10.41 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Mediwound has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from seekingalpha.com: MediWound Q3 2024 Earnings Preview |
- Analyzing Mediwound's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mediwound's stock is overvalued or undervalued compared to its peers.
- Examining Mediwound's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mediwound's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mediwound's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mediwound's stock. These opinions can provide insight into Mediwound's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |